# Waldencast plc > Clarifo company profile — qualitative business description generated from > the company's filings. Financial statements, charts and ratios are > available on Clarifo (https://www.clarifo.com/fi/companies/Waldencast plc). ## Overview Waldencast plc is a Jersey-incorporated beauty and wellness platform headquartered in London, with operations centered on branded cosmetics, makeup, skincare and related personal-care products. Its brand-led model develops, acquires, accelerates and scales purpose-driven brands while providing shared operating expertise and infrastructure; notable brands include Milk Makeup and Obagi Medical. ## Products & services • Milk Makeup color cosmetics and skincare • Obagi Medical professional skincare systems • Skincare for aging, acne and pigmentation concerns • Makeup emphasizing self-expression and inclusion • Brand development, acquisition and operating support - **Color cosmetics** (45%) — Makeup products sold under Milk Makeup, including complexion, color and tint products. - **Skincare** (40%) — Consumer and professional skincare products addressing aging, pigmentation, acne and sun damage. - **Brand platform services** (15%) — Centralized brand-building, commercial, operational and scaling capabilities supporting the portfolio. - Milk Makeup color cosmetics and skincare - Obagi Medical professional skincare systems - Products for aging, acne and pigmentation concerns - Inclusive, self-expression-oriented makeup products - Brand acquisition, development and operating support ## Customers Waldencast sells beauty products to consumers through retail, digital commerce and professional skincare channels. Milk Makeup appeals to consumers seeking expressive, inclusive and cruelty-free cosmetics, while Obagi Medical serves consumers and skincare professionals seeking research-based treatments for pigmentation, aging, acne and sun damage. Retailers, specialty beauty chains and professional providers extend the brands’ distribution and customer reach. - **Consumer makeup shoppers** (primary) — Buy Milk Makeup products for color cosmetics, self-expression and inclusive beauty positioning. - **Consumer skincare shoppers** (primary) — Purchase branded skincare addressing aging, pigmentation, acne and photodamage. - **Professional skincare providers** (primary) — Use or recommend Obagi Medical products within research-based skincare routines. - **Beauty retailers** (secondary) — Stock Waldencast brands to offer differentiated cosmetics and skincare assortments. - **Digital and social-commerce customers** (secondary) — Discover and purchase products through online channels and culturally relevant product launches. - Beauty consumers buying makeup for self-expression and inclusion - Skincare consumers treating aging, pigmentation, acne and sun damage - Professional skincare providers recommending Obagi Medical systems - Specialty beauty retailers seeking differentiated branded products - Digital shoppers responding to social and viral product discovery ## Geography Waldencast has a multinational corporate structure, with its principal executive office in London and substantial commercial exposure to the United States beauty market. Milk Makeup has been ranked by Sephora as the second clean beauty makeup brand in the United States, while Obagi Medical is described as a fast-growing U.S. professional skincare brand. The available reports do not disclose a country-level revenue split or authoritative geographic revenue breakdown. - Principal executive office is in London, United Kingdom - United States is a key market for Milk Makeup - United States is a core market for Obagi Medical - Products reach consumers through retail and digital channels - Country-level revenue percentages are not disclosed in the excerpts ## Strategy Waldencast’s strategy is to build a multi-brand beauty and wellness platform by acquiring, developing and scaling purpose-driven brands while preserving their distinct identities. Shared operating capabilities are intended to give entrepreneurial brands greater commercial scale, global expertise and market responsiveness. The portfolio approach also seeks to diversify exposure across makeup, skincare and related beauty categories. - **Scale the multi-brand beauty platform** (medium-term) — Shared infrastructure can improve distribution, expertise and speed across individual brands. - **Expand purpose-driven brand growth** (medium-term) — Distinct brand values and cultural relevance support customer acquisition in crowded beauty categories. - **Build science-led skincare exposure** (long-term) — Research-based products can strengthen differentiation and professional-channel credibility. - **Manage portfolio and capital allocation** (short-term) — Acquisitions and disposals shape brand concentration, leverage and the platform’s category mix. - Acquire and develop high-growth purpose-driven beauty brands - Preserve individual brand identities while sharing platform capabilities - Scale Milk Makeup through retail, digital and cultural relevance - Use research-based skincare positioning to support Obagi Medical - Diversify category exposure across makeup and skincare ## Risks Waldencast faces execution risk from integrating, scaling and allocating capital across acquired beauty brands, particularly when transaction proceeds, debt repayment and portfolio changes affect resources available for growth. Brand demand is sensitive to consumer preferences, social-media trends, retailer relationships and intense competition in cosmetics and skincare. Product claims, regulatory requirements, supply-chain constraints and impairment of acquired goodwill or intangible assets could also affect reported results and cash generation. - **Transaction execution and regulatory approval** [high] — The reported Obagi Medical transaction remains subject to customary closing conditions and approvals. - **Brand and consumer preference volatility** [high] — Beauty demand can change rapidly as social trends, product virality and customer tastes evolve. - **Retail and channel concentration** [medium] — Dependence on specialty retailers and professional channels can increase bargaining and distribution risk. - **Product and regulatory compliance** [high] — Cosmetic ingredients, labeling, safety and skincare claims are subject to changing regulations. - **Goodwill and intangible asset impairment** [high] — Acquired brands and platform assets may require write-downs if forecasts or brand performance weaken. - **Leverage and capital allocation** [high] — Senior secured debt and transaction-related obligations can reduce flexibility for brand investment. - Beauty trends can shift quickly and reduce product demand - Retailer concentration can affect distribution and bargaining power - Acquisition integration may dilute brand identity or execution speed - Regulatory claims rules affect skincare marketing and product sales - Goodwill and brand impairments may follow weaker performance - Debt and transaction obligations can constrain investment capacity ## Accounting Acquisitions and disposals require significant judgment in valuing brands, goodwill, contingent consideration and other acquired or transferred assets, with subsequent impairment testing potentially creating large earnings effects. The reported pro forma materials also identify disposal accounting, transaction adjustments, transition-service costs and effective-interest accretion on a vendor note as relevant presentation issues. Foreign-currency translation, valuation allowances and the timing of retail and professional product revenue can further affect comparability between periods. - **Goodwill and acquired brand impairment** — Potential non-cash charges can materially reduce operating income and equity. - **Disposal and pro forma accounting** — Reported historical and pro forma periods may not be directly comparable. - **Vendor note effective-interest accounting** — Finance income is recognized over the note’s carrying period. - **Transaction and transition-service costs** — Reported selling, general and administrative expenses may include non-recurring items. - **Foreign-currency translation** — Exchange-rate movements can affect comprehensive income without changing local-currency operations. - **Tax valuation allowances** — Reported tax expense and deferred tax assets may differ from statutory-rate expectations. - Brand and goodwill valuations drive impairment sensitivity - Disposal accounting changes historical revenue and expenses - Vendor-note accretion affects interest income over time - Transition-service costs affect post-transaction expenses - Foreign-currency translation affects comprehensive income - Tax valuation allowances may limit recognized tax benefits --- *Last updated: 2026-09-08T05:51:46.945180+00:00*